7th Annual Symposium in Translational Research in Pathology

Thursday, March 23, 2023, 1:00 PM - 7:00 PM, Zuckerman Research Center, 417 East 68th Street, New York, NY

The Gerald Award lecture is presented as part of our annual Symposium in Translational Research in Pathology, which features research presentations and a poster session from members of the MSK Pathology and Laboratory Medicine Department. This Symposium is designed to highlight new advances in the field of translational research as it relates to pathology.

The Memorial Sloan Kettering William L. Gerald Award is conferred on a pathologist whose recent innovative research has provided novel insights into cancer biology and whose career trajectory suggests the potential for outstanding contributions in the years to come.

The award reflects the contributions and values brought to the Department of Pathology by Dr. William L. Gerald, an Attending Pathologist at MSK from 1992 to 2008. A gifted morphologist, Dr. Gerald was committed to providing state-of-the-art patient care as a surgical pathologist and recognized that the molecular characterization of human neoplasms could affect the classification, prognostic assessment, and treatment of cancer. Dr. Gerald had broad diagnostic expertise but focused his clinical work on genitourinary pathology, and he was also the pediatric pathology consultant for the department. He was a pioneer in the molecular characterization of cancer at a time when now commonplace molecular techniques were still cutting-edge technology.

Dr. Gerald provided the first histologic description and subsequent molecular characterization of desmoplastic small round cell tumor, an entity that now bears his name. His work helped establish a novel molecular classification of neuroblastoma. He used gene expression analysis and other molecular assays to develop the prognostic characterization of prostate cancer.

Throughout his career, Dr. Gerald collaborated with and provided mentorship to numerous trainees and colleagues. His quiet good nature and thoughtful approach made him a model physician-scientist. He was approachable and always willing to provide key insights. This award is a tribute to his scientific contributions and personal attributes, and to the legacy he left behind.

Target Audience

This Symposium is directed toward practicing pathologists and research scientists, both in academic and private practice environments, as well as residents and fellows in pathology, who wish to broaden their understanding of neoplastic diseases.

1. Provide an overview of the latest developments in translational research in pathology

This Symposium is complimentary. Please complete registration through the 'Register' tab above in order to attend (registration is required).

In-person or Virtual Registration Available: This Symposium will be available in-person at Memorial Sloan Kettering's Zuckerman Research Center in New York City. A virtual option will also be available for those unable to join us in-person.

• In-person Registrants: While MSK requests that institutional guests are vaccinated against COVID-19, we are no longer requiring proof of vaccination. Additional details, including our current Health and Safety Protocols, can be accessed on our Visiting Us page. If you are not feeling well or exhibiting any symptoms of COVID-19, please refrain from attending an in-person event at MSK and contact [email protected] as soon as possible.
• Virtual Registrants: The virtual option for this program will be delivered through Zoom. Access details, including a link to Zoom and faculty disclosures, can be found in the confirmation email you receive after registration.

If you are registered for this Symposium and unable to attend, please email [email protected] to cancel your registration.

Industry professionals may attend MSK CME activities for their own education. Marketing, sales, and promotion of products and services is strictly prohibited at MSK CME activities. For more information, please visit our Help page.

Memorial Sloan Kettering Cancer Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

AMA Credit Designation Statement

MSK designates this live activity for a maximum of 3.50 AMA PRA Category 1 Credits™. Physicians should claim only credit commensurate with the extent of their participation in the activity.

ABPath CC Recognition Statement

This activity will offer 3.50 Lifelong Learning (CME) credit towards the American Board of Pathology’s Continuing Certification program.

MSK Course Directors 

Hikmat A. Al-Ahmadie, MD
Associate Attending, Genitourinary Pathology

Meera R. Hameed, MD
Chief, Surgical Pathology Service

Jorge S. Reis-Filho, MD, PhD, FRCPath
Chief, Experimental Pathology Service

Natasha Rekhtman, MD, PhD
Attending, Thoracic Pathology; Cytopathology

Mitigation of Relevant Financial Relationships

Memorial Sloan Kettering Cancer Center adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers, or others are required to disclose all relevant financial relationships with ineligible companies (commercial interests). All relevant financial relationships have been mitigated prior to the commencement of the activity.

Thursday, March 23, 2023